• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Using injectabIe fiIIers for midface rejuvenation

    2021-05-07 06:31:32BeatriceGoArieIFrostOrenFriedman
    Plastic and Aesthetic Research 2021年7期

    Beatrice C. Go, ArieI S. Frost, Oren Friedman

    1Department of Otorhinolaryngology, Hospital of University of Pennsylvania, Pennsylvania, PA 19104, USA.

    2Division of Facial Plastic & Reconstructive Surgery, Department of Otorhinolaryngology, Hospital of University of Pennsylvania,Pennsylvania, PA 19107, USA.

    ★co-first authors.

    Abstract

    Keywords: Hyaluronic acid, midface, nasolabial fold, mouth, aging, face, fillers

    INTRODUCTION

    Treating the aging face is a popular area of medicine, as every human is subject to the physiologic process of aging. Understanding the intrinsic physiological aging process is crucial for appropriate and individualized treatment selection. The age results in thinning of the epidermis, flattening of the dermal-epidermal junction, slower wound healing, and decreased cellular proliferation[1]. Reduced synthesis of collagen due to fibroblast aging and collagen damage change the overall composition of the skin[2,3]. Extrinsic aging, most commonly attributed to sun damage but also to tobacco use and gravity, can further exacerbate the appearance of dull, discolored, and wrinkled skin. Loss of subcutaneous volume from these mechanisms is the hallmark of the aging face. In the midface, deepening of the nasolabial folds and marionette lines around the mouth are attributed to the descent of nearby fat collections[4]. Additionally, significant atrophy of the deep facial fat that provides structural volume and support to the midface occurs with aging and has a profound impact on malar projection[5-7].

    A variety of treatment options for the aging face exist, and they include both surgical and nonsurgical alternatives. Since the introduction of facelift surgery in the early twentieth century, numerous developments have allowed for more satisfactory and long-lasting aesthetic results[8-10]. The modern-day rhytidectomy involves manipulation (i.e., plication, imbrication) of the superficial musculoaponeurotic system (SMAS). The deep-plane facelift has been touted as a procedure that better improves the nasolabial fold and malar fat pad[11]. This technique involves sub-SMAS dissection with the simultaneous release of midfacial ligaments, allowing for repositioning of the malar fat pad. In exchange, however, patients are subject to greater tissue trauma, longer operative time, and increased risk of damage to the facial nerve[10].Minimally invasive and noninvasive techniques such as the threadlift[12], S-Lift[13], and minimal access cranial suspension lift[14]are all attractive options, although the longevity of results is debated. No single approach to surgical intervention has been identified as ideal - patient need, patient choice, and surgeon preference tend to guide treatment selection[15,16].

    Soft tissue fillers represent the frontline of nonsurgical alternatives for facial rejuvenation. There are a plethora of options for dermal fillers with variations in material, permanency, viscosity (G’), elasticity (G’),and longevity. The Food and Drug Administration (FDA) has approved different injectables for specific areas of the face and disease processes, although off-label use to achieve facial rejuvenation is common practice. In the midface, injectable fillers appeal to diminish the appearance of nasojugal and nasolabial grooves and augment the malar region. The efficacy and safety profile of injectable fillers is well-reported,although the “temporary” nature of these products often necessitates multiple procedures. Though fortunately rare, intravascular infiltration and vascular compression by filler are concerning events and may lead to devastating complications[17]. Other nonsurgical options reported in the literature include intradermal botulinum toxin injection[18,19], acoustic wave therapy[20], laser[21], and ultrasound[22].

    There are a variety of injectable fillers available for the treatment of the aging midface. The objective of this review is to describe the mechanism of action, indication, technique, and evidence of efficacy and safety.Understanding the advantages and limitations of injectable fillers for midface augmentation allows providers to appropriately counsel and treat patients.

    HyaIuronic acid

    The first soft-tissue fillers derived from bovine collagen in 1981 were immunogenic and caused inflammatory reactions[23]. The next generation of injectable fillers included hyaluronic acid (HA), an injectable extracellular matrix component. HA is a non-sulfated glycosaminoglycan composed of polymeric disaccharides with the unique property of forming stable structures in aqueous solutions[24]. The biological functions of HA throughout the body include lubrication of joint spaces and repair of tissue injury and wound healing[25]. In addition, dermal HA is diminished during the aging process, leading to loss of skin moisture, skin atrophy, and loss of elasticity[26]. Due to its molecular consistency across species, the minimal immunogenicity and relative ease of use have allowed HA fillers to be the most commonly used soft-tissue filler today[27].

    As a general guideline, injection of HA fillers is performed using 27- or 30-gauge needles along Hinderer’s lines: two intersecting lines from the ala to the tragus and lateral canthus to lateral oral commissure[28][Figure 1]. The filler is then ideally placed in the upper outer quadrant. Volume replacement targeting specific midface areas is dependent on location and requires meticulous attention to ethnic differences in bony anatomy[29]. The upper cheek, lateral cheek, anterior cheek, and medial cheek are all potential injection sites, and injectors must take precautions to avoid the zygomatic neurovascular bundle, infraorbital artery and vein, and angular artery and vein[30]. Volume replacement in the lid-cheek junction (“tear trough”) can be achieved with two or three injections along the nasojugal fold though care must be taken to avoid injury to vessels and orbital content[31]. There are two strategies to approach the submalar area: subcutaneous injection at numerous sites per side or a single medial subcutaneous injection using a fanning technique[32].Providers should take care to avoid the facial vessels and parotid duct during both techniques. Volume replacement in the preauricular area can be accomplished with three to five superficial injection sites with care to avoid the parotid gland and transverse facial artery and vein[33].

    Figure 1. Hinderer’s lines (two intersecting lines: ala/tragal, lateral canthal/commissure).

    The first HA-based filler approved for use by the United States FDA was Restylane (Galderma, Fort Worth,TX) in 2003[34,35]. There are now many other products that differ in concentration, elastic modulus, and degree of cross-linking, including Juvederm (Allergan Inc., Pringy, France), which has been approved for a variety of indications, including correction of facial wrinkles and folds as well as lip and cheek augmentation. Additional modifications on these products, including a new product with increased crosslinking (Teosyal resilient HA, Geneva, Switzerland), have been created to help reduce degradation due to mechanical strain[36]. Multiple randomized controlled trials have demonstrated the efficacy of HA for agerelated midface volume deficit. In a multicenter, single-blinded, controlled study, 85.6% of subjects treated with Juvederm Voluma demonstrated a significant improvement of 1 point or more at 6 months follow-up on the Mid-Face Volume Deficit Scale, a validated blinded clinician score, compared with the control group[37]. There were minimal adverse events, and more than half of the subjects reported lasting efficacy at 24 months. A follow-up study on patient satisfaction showed that nearly 93% and 79% of patients at 6 months and 2 years after treatment, respectively, noted improvement on the Global Aesthetic Improvement Scale[38]. In addition, patients reported looking 5 years younger at 6 months and 3 years younger at 2 years.Newer split-face trials are now comparing Cohesive Polydensified Matrix (CPM) (Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) with FDA-approved Vycross technology (Allergan Inc., Pringy,France), noting noninferior aesthetic results and more favorable safety and patient satisfaction profiles with CPM[39,40].

    CaIcium hydroxyIapatite

    Calcium hydroxylapatite (CaHa) is a unique compound with dual functionality as a replacement volumizer as well as a collagen biostimulator[41]. Due to its identical composition to human bone and teeth, CaHa is biodegradable, naturally resorbable, nontoxic, nonantigenic, and long-lasting, allowing for optimal biocompatibility and efficacy as a filler material[42]. CaHa’s biostimulatory effects work by immediately creating volume while encouraging a fibroblastic response and acting as a scaffold for newly formed collagen after natural resorption and excretion[43-45]. CaHa has a wide range of indications beyond aesthetics,including correction of orthopedic[46]and dental defects[47]and vocal fold augmentation[48]. In 2006, Radiesse(Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) was FDA-approved for the correction of moderate to severe midface wrinkles and folds and lipoatrophy in patients with human immunodeficiency virus. Radiesse utilizes a 30:70 ratio mixture of CaHa microspheres to aqueous carrier gel and has been well studied in facial aesthetic medicine[42,49,50].In the midface, restoration of the cheekbones allows for correction of specific creases and defects while providing volume to the malar and submalar regions. By augmenting the upper maxillary region, the shadowing effect seen with midface defects is ameliorated, resulting in a younger appearance[51]. CaHa can be placed using a similar technique to HA, though a larger bore needle or cannula is recommended due to the relative viscosity[52]. To achieve optimal aesthetic results, augmentation of the entire cheek and adjacent areas should be considered, not just the area of the defect[49]. Injection depth depends on location; superior to the alar-tragal line, CaHa should be injected superior to the periosteum, while subdermal injections are ideal for targeting areas inferior to the alar-tragal line[53]. After product placement, light massaging and molding of the filler are recommended to blend the injectable and reduce tissue edema and ecchymosis,thereby helping to achieve the desired outcome[42].

    There is a plethora of data supporting the long-term safety and efficacy of CaHa for facial soft-tissue augmentation. The first pivotal multi-center study comparing CaHa against human collagen in a randomized split-face trial reported significantly longer-lasting correction of nasolabial folds with less material used and fewer injections[54]. A follow-up safety study of 113 patients over 47 months showed only seven minor adverse events, including transient ecchymosis, submucosal nodules, and inflammation and edema[55]. Duration of action ranges from 12 to 18 months though long-term effectiveness of up to 30 months has been reported[56]. Despite these promising results, one systematic review reported that Radiesse was significantly more likely to result in intra-arterial complications and skin necrosis when compared with other facial fillers[57]. It is thought that the larger particle size of Radiesse increases the propensity of vascular compromise. Thus, the provider must remain vigilant to avoid vascular complications.

    PoIy-L-Iactic acid

    Poly-L-lactic acid (PLLA) is an absorbable, semi-permanent, biocompatible synthetic polymer that induces collagen synthesis, leading to volume restoration. After injection, PLLA particles stimulate an inflammatory response with tissue macrophages, leading to degradation into lactic acid and subsequently carbon dioxide and water[58]. This process promotes the formation of new type-I collagen as well as fibroblast activity,leading to gradual volume replacement[59]. The effect of PLLA stems from the natural host response rather than the immediate volume increase, thus leading to an extended duration of action from 12 to 24 months[60].

    In the United States, Sculptra (Galderma, Fort Worth, TX) has been FDA-approved for facial lipoatrophy associated with HIV and more recently in 2009 for the correction of shallow to deep nasolabial folds and other facial wrinkles[17]. The product must be reconstituted with Sterile Water for Injection (5 mL) prior to injection to form a sterile suspension[61]. When approaching the midface, supraperiosteal injections over the zygoma, maxilla, and temples and subcutaneous injections in the submalar and preauricular areas are recommended[62]. Consensus guidelines recommend 3-5 initial sessions for optimal results, with at least four weeks between sessions. Patients should be counseled that cosmetic effects have a gradual onset and can last two years or more[62]. Due to the slowly progressive bulking effects of PLLA, it is important to not overcorrect the treatment area with too much filler[63].

    Multiple retrospectives and prospective cohort studies have demonstrated the safety of injectable PLLA[64-67].For example, a pivotal randomized, single-blinded, multicenter trial in 2010 compared the efficacy and safety of PLLA with human-derived collagen for nasolabial fold deficits[68]. Subjects receiving injectable PLLA had significantly improved average Wrinkle Assessment Scale scores at all-time points up to 25 months compared with the control group. Other similar trials have reported high provider and patient satisfaction with results[69,70]. Compared to HA fillers, PLLA was found to be noninferior in the correction of moderate to severe nasolabial folds and appeared to be superior to HA in patients less than 52 years of age[71]. Main adverse effects include papules and nodules stemming from unequal distribution, inaccurate placement, and incorrect reconstitution[72]. As preparation and administration of PLLA have become increasingly standardized, however, the frequency of post-injection complications has also decreased[73].

    PoIymethyI methacryIate

    Polymethyl methacrylate (PMMA) is a synthetic, biologically compatible, inert, nonbiodegradable polymer originally used in dental and orthopedic procedures. Although a previous version (Artecoll, Canderm Pharma Inc, Canada) was marketed outside of the United States, newer generations of PMMA injectable fillers (ArteFill, later rebranded as Bellafill, Suneva Medical, San Diego, CA, USA) have been FDA approved for nasolabial fold augmentation since 2006[17,74]. These formulations contain PMMA microspheres, which are evenly distributed among denatured bovine collagen and lidocaine. Compared to other injectable filler materials, PMMA is a small, smooth permanent filler without electrical charge, thus preventing phagocytosis and degradation by macrophages[75]. Initial volume restoration is attributed to the collagen content in the filler though after this component is resorbed after 1 to 3 months, PMMA microspheres become permanently encapsulated with connective tissue and cells[76]. Due to the bovine collagen suspension, skin allergy testing must be conducted 2-4 weeks prior to injection, and double skin testing is often recommended to reduce the severity and incidence of allergic reactions[77]. On account of its permanent nature, the administration of PMMA requires careful attention to detail and placement. PMMA should be implanted intradermally, just superior to the dermis and subcutaneous layer[78]. The tunneling technique, or moving the needle back and forth beneath a wrinkle, allows for even distribution and layering of the product.

    PMMA was initially introduced worldwide in the 1990s and became approved in 2006 after a multicenter randomized controlled trial of 251 subjects receiving Artecoll for a variety of facial wrinkles reported superior results to collagen dermal filler[78]. At 6 months follow-up, investigator and subject satisfaction ratings were higher at all injection sites, and significant augmentation was present at 12 months follow-up.After Artecoll, the next generation of PMMA was named Artefill, which boasted greater uniformity in size,surface contour, smoothness, and roundness[79]. Since then, PMMA has been repackaged as Bellafill, which offers a very favorable risk/benefit profile when administered properly. Short-term complications (tissue necrosis, infection) and long-term sequelae (granulomas, chronic inflammatory reaction) have been reported though they are fortunately rare occurrences[80]. A total of 1008 subjects receiving PMMA fillers for nasolabial folds was followed over five years, with biopsy-confirmed granulomas occurring in 1.7%[81].Almost all granulomas resolved with intralesional corticosteroid injections, and overall satisfaction rates remained high through the study period. In the event of nodules, skin changes, or contour irregularity,another study reported that surgical debulking of material could reduce the effects of these complications[82]. Long-term data also supports an excellent safety profile for this filler type. Surveillance data from 2007 to 2016 for more than half a million Bellafill syringes showed 11 total confirmed granulomas(0.002% or syringes sold)[79].

    FiIIers vs. surgery

    Although deep dermal fillers offer safe and excellent cosmetic results, it is important to consider which patients would likely benefit more from surgery. For those with more significant midface ptosis and facial volume loss, the more permanent and dramatic effects of rhytidectomy are more appealing. The main goals of the midface lift include effacement of the lower lid-cheek junction with volume restoration of the cheek and malar eminence[83]. Although a thorough discussion of surgical techniques is out of the scope of this review, providers must evaluate which patients would benefit from fillers, surgery, or a combination of both.During this conversation, differences in expected outcomes and recovery for the treatment options should be covered. If patients are willing to undergo general anesthesia and have significant soft tissue ptosis, most experts agree that a midface lift may be the more appropriate solution[83]. The addition of soft tissue fillers should be a separate discussion after the patient has had ample time to recover, allowing for the settling of the soft tissue.

    Midface surgical options can confer longer-lasting results when compared with midface fillers. In a series of 157 patients undergoing a primary facelift at age < 50, patients reported appearing significantly younger after facelift compared with after nonsurgical intervention (8 yearsvs.4 years,P= 0.048)[84]. Thirty-two percent of patients underwent an average of 7 rounds of injectable fillers prior to surgical intervention, with an average expenditure of $7000 on nonsurgical procedures. Longevity of midface lift approaches has been reported, although most outcome measures are largely subjective, citing high patient satisfaction and quality of life scores at up to 5 years follow-up[85,86]. A recent study described a series of 143 patients undergoing an endoscopic transtemporal approach, reporting a significant, objective improvement in midfacial height that persisted for up to 15 years[87]. Despite these encouraging and lasting aesthetic results, no procedure is without its risks, which must be extensively discussed when counseling patients. The complications of midface lift surgery include asymmetry, infection, hematoma, facial and trigeminal neuropathy, and undesired scarring[88].

    DISCUSSION

    Management of the midface with volume augmentation can be safely and effectively achieved with the use of soft tissue injectable fillers. The selection of filler is largely dependent on patient factors, including the severity of ptosis, degree of volume loss, age, cost, preference, and surgical candidacy[88]. From the provider’s perspective, a detailed understanding of anatomy in the nasal region as well as proper technique is fundamental to minimizing the risk of complications and achieving the desired effect.

    For decades, surgical rhytidectomy was established as the frontline procedure to enable patients to achieve predictable, customizable, and natural-looking results. However, the popularity of minimally invasive techniques has increased rapidly due to the introduction and wide acceptance of soft tissue fillers. Among the younger patient population that is not quite ready for a facelift, injectable fillers are an attractive, less permanent alternative to surgery. Compared to undergoing more invasive surgery, fillers offer the patient less discomfort and a shorter recovery time, making them very practical. Additionally, new and innovative advances to avoid anatomic danger zones and improve overall technique have led to safer injection practices[89-91]. Needle aspiration prior to injecting the filler has been reported to help prevent accidental intravascular injection[92]. With appropriate handling and adequate experience, injectable fillers are a safe and effective option for the aging midface.

    The increasing popularity of facial fillers is well reflected in popular media and online news coverage. For example, a Google News search for articles on “facial fillers” from 2008 to 2017 reported coverage as 45%positive, 30% neutral, and 25% negative[93]. While most media coverage at national and international levels was fairly positive, there was some concern with the regulation of facial fillers, a salient issue that may incite apprehension in some patients interested in the procedure. Additionally, nearly half of the papers discussed complications associated with the procedure despite the overall rarity of vascular injury and blindness[94,95].As most cases of vision loss do not recover, and there is no consistent treatment for blindness, it is crucial for providers to understand the risks involved with the procedure and appropriately counsel patients[96].

    From an economic standpoint, the short-term cost of injectable fillers is another advantage for patients seeking minimally invasive treatment. However, a study by Biskupiak and Sclafani among several facial plastic surgeries and dermatology practices in New York City estimated that the total medical cost for surgical rhytidectomy was around $10,181[97]. When comparing this value to large-volume facial soft tissues assuming 90 months of the desired effect, the medical cost for surgery was the lowest cost option among the other treatments. When considering total costs, including workdays lost, ArteFill ($11,151 for 1 treatment)and Sculptra ($14,850 for 3.75 treatments) were less costly than surgical rhytidectomy ($15,181). This discrepancy was attributed to extra fees due to anesthesia, operating room, and overhead hospital costs, as well as the lengthier recovery period for surgery. However, it is important to consider that a rhytidectomy may ultimately be more cost-effective compared to patients undergoing large-volume filler augmentation over the course of several years.

    There are multiple advances in filler technology to increase longevity while improving efficacy and safety profiles. For example, a new line of dermal fillers, called resilient hyaluronic acid (RHA) (Revance Therapeutics, Nashville, TN), was designed with a cross-linking method to mimic the function of native HA better. It is thought that these products (RHA 2, 3, 4) are able to adapt to facial movements to treat dynamic wrinkles and folds, a typical indication for neuromodulators[98]. Recently FDA approved for the correction of deep dynamic wrinkles, including the nasolabial folds; RHA 2 and 3 are indicated for injection into the mid-to-deep dermis, while RHA 4 is indicated for injection into the deep dermis to superficial subcutaneous tissue[99]. One split-face, randomized controlled trial on 90 subjects with moderate to severe nasolabial folds found at least equivalent efficacy and safety profiles with comparable fillers[100]. However, immediate and long-term satisfaction for both investigators and subjects favored RHA fillers with no reports of serious adverse events. At this time of writing, other dermal fillers expected to come to the United States market include Juvederm Volite (Allergan, Dublin, Ireland), the HA-based filler meant to improve skin quality, and ProfHilo (IBSA Nordic ApS, Denmark), another HA-based filler without any chemical cross-linking agents[101,102].

    CONCLUSION

    As a result of volume loss and fat atrophy, the aging midface is characterized by overall drooping of soft tissues and deepening of the nasolabial folds. Although surgical rhytidectomy is a long-lasting option for these patients, recent nonsurgical avenues, including filler injections, are becoming more popular due to reduced patient discomfort and recovery times. While filler selection may depend on patient preference and individual goals, providers must remain informed on the potential complications associated with midface augmentation and provide appropriate preprocedural counseling.

    DECLARATIONS

    Authors’ contributions

    Made substantial contributions to conception and design of the study, performed interpretation of data for the work, drafted the work, gave final approval of the version to be published, agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: Go BC, Frost AS

    Made substantial contributions to conception and design of the study, revised it critically for important intellectual content, gave final approval of the version to be published, agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: Friedman O

    AvaiIabiIity of data and materiaIs

    Not applicable.

    FinanciaI support and sponsorship

    None.

    ConfIicts of interest

    All authors declared that there are no conflicts of interest.

    EthicaI approvaI and consent to participate

    Not applicable.

    Consent for pubIication

    Not applicable.

    Copyright

    ? The Author(s) 2021.

    亚洲av熟女| 日韩一区二区三区影片| 国产老妇伦熟女老妇高清| 99热这里只有精品一区| 欧美+日韩+精品| 国产三级中文精品| 97在线视频观看| 日韩欧美精品免费久久| 老女人水多毛片| 欧美激情久久久久久爽电影| 亚洲av中文av极速乱| 长腿黑丝高跟| 1024手机看黄色片| 一级毛片aaaaaa免费看小| 大香蕉久久网| 久久精品国产亚洲av香蕉五月| 校园人妻丝袜中文字幕| 特大巨黑吊av在线直播| 久久久久久久久久成人| eeuss影院久久| 免费大片18禁| 国产v大片淫在线免费观看| 久久久久久久久中文| 国产精品一区二区性色av| 久久精品国产清高在天天线| 国产亚洲精品久久久com| 直男gayav资源| 婷婷亚洲欧美| 99久久精品热视频| 男插女下体视频免费在线播放| 99久久人妻综合| 老熟妇乱子伦视频在线观看| avwww免费| 亚洲av第一区精品v没综合| 少妇人妻精品综合一区二区 | 国产一区二区三区av在线 | 免费无遮挡裸体视频| av国产免费在线观看| 国产精品女同一区二区软件| 99久国产av精品| 伦精品一区二区三区| 只有这里有精品99| or卡值多少钱| 国产中年淑女户外野战色| 成人欧美大片| 亚洲真实伦在线观看| 狂野欧美激情性xxxx在线观看| 亚洲国产精品成人久久小说 | 99九九线精品视频在线观看视频| 久久精品国产99精品国产亚洲性色| 亚洲精华国产精华液的使用体验 | 蜜桃久久精品国产亚洲av| 国内精品一区二区在线观看| 九九久久精品国产亚洲av麻豆| 欧美激情在线99| 欧美极品一区二区三区四区| 99久久九九国产精品国产免费| 免费观看a级毛片全部| 日本av手机在线免费观看| 久久久久免费精品人妻一区二区| 精品久久久久久成人av| 成人漫画全彩无遮挡| 一本一本综合久久| 最近最新中文字幕大全电影3| 搞女人的毛片| 99久国产av精品国产电影| 国产黄色小视频在线观看| 国产成人影院久久av| 亚洲av电影不卡..在线观看| 免费av观看视频| 高清午夜精品一区二区三区 | 好男人视频免费观看在线| 国产黄色视频一区二区在线观看 | 成人欧美大片| 国产免费一级a男人的天堂| 日韩欧美一区二区三区在线观看| 天美传媒精品一区二区| 免费在线观看成人毛片| 欧美另类亚洲清纯唯美| 99热精品在线国产| 国内精品久久久久精免费| 丝袜喷水一区| 九九爱精品视频在线观看| 午夜精品国产一区二区电影 | 99久国产av精品| 日本黄色片子视频| 人妻久久中文字幕网| 91精品国产九色| 久久久久久久亚洲中文字幕| 99久久精品一区二区三区| 国产毛片a区久久久久| 欧美日韩一区二区视频在线观看视频在线 | 国产成人午夜福利电影在线观看| 91午夜精品亚洲一区二区三区| or卡值多少钱| 别揉我奶头 嗯啊视频| 欧美最新免费一区二区三区| 久久中文看片网| 在现免费观看毛片| 成人午夜精彩视频在线观看| 男人舔奶头视频| 99九九线精品视频在线观看视频| 高清在线视频一区二区三区 | 久久99精品国语久久久| av卡一久久| 国产av一区在线观看免费| 国产亚洲精品久久久久久毛片| 黑人高潮一二区| 亚洲国产色片| 日韩成人伦理影院| 看非洲黑人一级黄片| 91久久精品国产一区二区成人| 亚洲不卡免费看| 美女脱内裤让男人舔精品视频 | 国产久久久一区二区三区| 在线观看66精品国产| 99热只有精品国产| 久久99热6这里只有精品| 国内精品一区二区在线观看| 亚洲av成人av| 干丝袜人妻中文字幕| 大香蕉久久网| 色哟哟·www| 国产69精品久久久久777片| 日韩国内少妇激情av| 亚洲欧洲国产日韩| 日韩 亚洲 欧美在线| av在线亚洲专区| 精品国产三级普通话版| 人妻少妇偷人精品九色| 人妻制服诱惑在线中文字幕| 国产高清视频在线观看网站| 免费看日本二区| 三级男女做爰猛烈吃奶摸视频| 国产精品人妻久久久影院| 最近的中文字幕免费完整| 内射极品少妇av片p| 男女做爰动态图高潮gif福利片| 性色avwww在线观看| 国产色婷婷99| 国产精品福利在线免费观看| 男人的好看免费观看在线视频| 日韩一区二区视频免费看| 亚洲乱码一区二区免费版| 欧美zozozo另类| 国产 一区 欧美 日韩| 日本黄大片高清| 亚洲精品国产成人久久av| 一级av片app| 国产精品一区二区在线观看99 | 日本免费一区二区三区高清不卡| 岛国在线免费视频观看| 国产伦精品一区二区三区四那| 精品人妻视频免费看| 国产成人a∨麻豆精品| av在线老鸭窝| 男女啪啪激烈高潮av片| 中国美女看黄片| 啦啦啦韩国在线观看视频| av在线观看视频网站免费| 免费搜索国产男女视频| 亚洲人成网站在线观看播放| 日韩欧美一区二区三区在线观看| 桃色一区二区三区在线观看| 亚洲一区二区三区色噜噜| 91久久精品国产一区二区三区| 蜜桃亚洲精品一区二区三区| 夜夜看夜夜爽夜夜摸| 亚洲精品国产成人久久av| 成人亚洲精品av一区二区| 中文亚洲av片在线观看爽| 床上黄色一级片| 久久草成人影院| 日本黄色视频三级网站网址| 狠狠狠狠99中文字幕| 中文字幕人妻熟人妻熟丝袜美| 成人毛片a级毛片在线播放| 亚洲av一区综合| 又爽又黄a免费视频| 又粗又爽又猛毛片免费看| av视频在线观看入口| 十八禁国产超污无遮挡网站| 精华霜和精华液先用哪个| 久久午夜亚洲精品久久| 99久久九九国产精品国产免费| 长腿黑丝高跟| 99久久成人亚洲精品观看| ponron亚洲| 国产高清有码在线观看视频| 亚洲人成网站高清观看| 国产三级在线视频| 麻豆成人午夜福利视频| 女同久久另类99精品国产91| 久久久久久久久中文| 亚洲欧美日韩无卡精品| 99久久无色码亚洲精品果冻| 干丝袜人妻中文字幕| 观看美女的网站| 你懂的网址亚洲精品在线观看 | 精品少妇黑人巨大在线播放 | 亚洲精品乱码久久久久久按摩| 91aial.com中文字幕在线观看| 精品午夜福利在线看| 亚洲va在线va天堂va国产| 99热全是精品| 国产午夜精品一二区理论片| 国内少妇人妻偷人精品xxx网站| 亚洲熟妇中文字幕五十中出| 久久九九热精品免费| 亚洲图色成人| 可以在线观看毛片的网站| 久久亚洲国产成人精品v| 国产精品一区二区性色av| avwww免费| 成人特级av手机在线观看| 免费搜索国产男女视频| 国产真实乱freesex| 别揉我奶头 嗯啊视频| 不卡视频在线观看欧美| 成年女人看的毛片在线观看| 中文欧美无线码| 亚洲av成人av| 性插视频无遮挡在线免费观看| 成人av在线播放网站| 亚洲第一电影网av| 天天一区二区日本电影三级| 男人舔奶头视频| 亚洲高清免费不卡视频| 日韩,欧美,国产一区二区三区 | 一本一本综合久久| 在线观看66精品国产| 成人漫画全彩无遮挡| 久久久久久久亚洲中文字幕| 国内揄拍国产精品人妻在线| 女人被狂操c到高潮| 午夜福利在线观看免费完整高清在 | 中文字幕人妻熟人妻熟丝袜美| 国产av在哪里看| 99riav亚洲国产免费| 日韩在线高清观看一区二区三区| 久久精品影院6| 人妻久久中文字幕网| 亚洲激情五月婷婷啪啪| 日本一二三区视频观看| h日本视频在线播放| 亚洲无线在线观看| 日韩一区二区三区影片| 免费人成在线观看视频色| 啦啦啦啦在线视频资源| 久久人人爽人人片av| 亚洲国产精品合色在线| 国产精品免费一区二区三区在线| 国产老妇伦熟女老妇高清| 亚洲av成人精品一区久久| 三级国产精品欧美在线观看| 精品午夜福利在线看| 国产精品一区www在线观看| 观看免费一级毛片| 国产高清不卡午夜福利| 免费av毛片视频| 好男人视频免费观看在线| 如何舔出高潮| 内射极品少妇av片p| 天堂av国产一区二区熟女人妻| a级毛色黄片| 亚洲国产精品国产精品| 欧美激情国产日韩精品一区| 免费观看a级毛片全部| 午夜老司机福利剧场| 国产在视频线在精品| 国产伦一二天堂av在线观看| 国内少妇人妻偷人精品xxx网站| 九九久久精品国产亚洲av麻豆| 嫩草影院新地址| 一本久久中文字幕| 极品教师在线视频| 精品久久久久久久人妻蜜臀av| 亚洲国产高清在线一区二区三| 深夜精品福利| 嫩草影院新地址| 精品无人区乱码1区二区| 99久久精品一区二区三区| 不卡一级毛片| 国产av不卡久久| av女优亚洲男人天堂| 亚洲三级黄色毛片| 两个人的视频大全免费| 爱豆传媒免费全集在线观看| 成人无遮挡网站| 亚洲不卡免费看| 国产亚洲5aaaaa淫片| 日韩亚洲欧美综合| 寂寞人妻少妇视频99o| 毛片一级片免费看久久久久| 亚洲最大成人中文| 综合色丁香网| 麻豆成人av视频| 亚洲欧洲日产国产| a级一级毛片免费在线观看| av又黄又爽大尺度在线免费看 | 国产精品美女特级片免费视频播放器| 免费观看在线日韩| 欧美xxxx黑人xx丫x性爽| 欧美人与善性xxx| 日韩强制内射视频| 国产成人午夜福利电影在线观看| 丰满乱子伦码专区| 青春草视频在线免费观看| 国产精品久久久久久精品电影| 99久国产av精品| 免费看a级黄色片| 51国产日韩欧美| 麻豆久久精品国产亚洲av| 能在线免费看毛片的网站| 国产精品国产高清国产av| 国内精品美女久久久久久| 综合色丁香网| 欧美变态另类bdsm刘玥| 九色成人免费人妻av| 久久人妻av系列| 亚洲欧美成人综合另类久久久 | 亚洲图色成人| 深夜a级毛片| 中文字幕精品亚洲无线码一区| 日本黄大片高清| 亚洲精品国产av成人精品| 看十八女毛片水多多多| 美女内射精品一级片tv| 国产老妇女一区| 亚洲aⅴ乱码一区二区在线播放| 在线国产一区二区在线| a级毛片a级免费在线| 联通29元200g的流量卡| 国产国拍精品亚洲av在线观看| 日韩欧美国产在线观看| 日韩欧美三级三区| 成人综合一区亚洲| 九色成人免费人妻av| 国内精品久久久久精免费| 久久久久久久久久黄片| 成人综合一区亚洲| 国产精品三级大全| 久久久久久久久中文| 97在线视频观看| 国产精品野战在线观看| 国国产精品蜜臀av免费| 乱码一卡2卡4卡精品| 日产精品乱码卡一卡2卡三| 一级毛片电影观看 | 亚洲av成人精品一区久久| 久久精品91蜜桃| a级毛片免费高清观看在线播放| 亚洲精品456在线播放app| 又爽又黄无遮挡网站| 国语自产精品视频在线第100页| 爱豆传媒免费全集在线观看| 人妻系列 视频| 免费看光身美女| 丰满的人妻完整版| 国产人妻一区二区三区在| 国产激情偷乱视频一区二区| 日产精品乱码卡一卡2卡三| 亚洲av男天堂| 国产精品久久电影中文字幕| 日韩人妻高清精品专区| 欧美成人一区二区免费高清观看| 一级毛片aaaaaa免费看小| 国产精品免费一区二区三区在线| 成熟少妇高潮喷水视频| 我的老师免费观看完整版| 中国美女看黄片| 国产伦在线观看视频一区| 九色成人免费人妻av| 精品无人区乱码1区二区| h日本视频在线播放| 亚洲国产欧美人成| 成人鲁丝片一二三区免费| 你懂的网址亚洲精品在线观看 | 久久综合国产亚洲精品| 日本撒尿小便嘘嘘汇集6| 亚洲国产精品合色在线| 国产男人的电影天堂91| 久久人人爽人人片av| 日韩国内少妇激情av| 亚洲自偷自拍三级| 中文字幕制服av| 国产爱豆传媒在线观看| 美女国产视频在线观看| 99在线人妻在线中文字幕| 亚洲一区高清亚洲精品| 人妻夜夜爽99麻豆av| 亚洲aⅴ乱码一区二区在线播放| 国产在视频线在精品| 免费观看a级毛片全部| 国产精品美女特级片免费视频播放器| 人体艺术视频欧美日本| 天美传媒精品一区二区| 99久久精品一区二区三区| 91麻豆精品激情在线观看国产| 欧美另类亚洲清纯唯美| 97人妻精品一区二区三区麻豆| 亚洲精品国产av成人精品| 日本成人三级电影网站| 嫩草影院新地址| 国产伦理片在线播放av一区 | 久久久久性生活片| 22中文网久久字幕| 一级毛片我不卡| 小蜜桃在线观看免费完整版高清| 色综合亚洲欧美另类图片| 久久精品久久久久久久性| 午夜福利在线观看免费完整高清在 | 色视频www国产| 国产精品一区二区性色av| 午夜老司机福利剧场| 国内精品一区二区在线观看| 成人漫画全彩无遮挡| 亚洲成av人片在线播放无| 久久精品影院6| 观看免费一级毛片| 高清日韩中文字幕在线| 久久精品国产亚洲av天美| 色噜噜av男人的天堂激情| 国产精品蜜桃在线观看 | 精品免费久久久久久久清纯| 国产综合懂色| 久久婷婷人人爽人人干人人爱| 国产一级毛片在线| 大型黄色视频在线免费观看| 午夜福利在线观看吧| 黄色日韩在线| 天天躁日日操中文字幕| 91狼人影院| 欧美性感艳星| 亚洲无线观看免费| 中文字幕熟女人妻在线| 亚洲成av人片在线播放无| 成人特级av手机在线观看| 亚洲人成网站高清观看| 成人国产麻豆网| 国产老妇伦熟女老妇高清| 我的老师免费观看完整版| 亚洲av免费高清在线观看| 国语自产精品视频在线第100页| 国产精品精品国产色婷婷| 国内精品久久久久精免费| 亚洲一区二区三区色噜噜| av视频在线观看入口| 成年版毛片免费区| 18禁在线播放成人免费| 国产探花在线观看一区二区| 99久久精品热视频| 99久久人妻综合| 久久精品国产清高在天天线| 精品人妻一区二区三区麻豆| 久久久久久久久大av| 真实男女啪啪啪动态图| 97超视频在线观看视频| av在线老鸭窝| 国产精品久久久久久精品电影| 极品教师在线视频| 亚洲成人精品中文字幕电影| 日产精品乱码卡一卡2卡三| 久久午夜亚洲精品久久| 人妻夜夜爽99麻豆av| 国产老妇伦熟女老妇高清| 亚洲电影在线观看av| 精品欧美国产一区二区三| 麻豆久久精品国产亚洲av| 亚洲欧美中文字幕日韩二区| 麻豆久久精品国产亚洲av| 春色校园在线视频观看| 国产成人freesex在线| 偷拍熟女少妇极品色| 在线国产一区二区在线| 亚州av有码| 高清毛片免费看| 亚洲成人精品中文字幕电影| 51国产日韩欧美| 日韩欧美 国产精品| 给我免费播放毛片高清在线观看| 欧美最新免费一区二区三区| 卡戴珊不雅视频在线播放| 久久精品国产亚洲av涩爱 | 亚洲成av人片在线播放无| 亚洲欧洲日产国产| 国产欧美日韩精品一区二区| 亚洲精品色激情综合| 丝袜喷水一区| 我的女老师完整版在线观看| 99久久人妻综合| 草草在线视频免费看| 九九爱精品视频在线观看| 只有这里有精品99| 亚洲人与动物交配视频| 国产亚洲精品久久久久久毛片| 一边摸一边抽搐一进一小说| 99久久九九国产精品国产免费| 听说在线观看完整版免费高清| 亚洲三级黄色毛片| a级毛片a级免费在线| 国产成人一区二区在线| 听说在线观看完整版免费高清| 国语自产精品视频在线第100页| 亚洲国产精品成人久久小说 | 国产精品麻豆人妻色哟哟久久 | 变态另类丝袜制服| 内射极品少妇av片p| 男插女下体视频免费在线播放| 午夜福利在线在线| 亚洲图色成人| 久久久久久大精品| 免费无遮挡裸体视频| 国产真实乱freesex| 欧美日韩精品成人综合77777| 国产成人精品一,二区 | 成人特级黄色片久久久久久久| 免费在线观看成人毛片| 国产伦精品一区二区三区视频9| 美女被艹到高潮喷水动态| av视频在线观看入口| 1000部很黄的大片| 精品日产1卡2卡| 亚洲自偷自拍三级| 不卡视频在线观看欧美| 日韩亚洲欧美综合| 婷婷色综合大香蕉| 午夜精品一区二区三区免费看| 少妇裸体淫交视频免费看高清| 在线天堂最新版资源| 亚洲成a人片在线一区二区| 91麻豆精品激情在线观看国产| 国产精品野战在线观看| 国产成人a∨麻豆精品| 精品人妻偷拍中文字幕| 亚洲不卡免费看| 欧美一区二区国产精品久久精品| 黄色日韩在线| 免费在线观看成人毛片| 亚洲av.av天堂| 久久亚洲国产成人精品v| 成人午夜高清在线视频| 在线观看66精品国产| 99久国产av精品国产电影| 在线观看av片永久免费下载| 久久精品夜色国产| 久久99蜜桃精品久久| 精品人妻熟女av久视频| 婷婷亚洲欧美| 99国产精品一区二区蜜桃av| 成年版毛片免费区| 一边摸一边抽搐一进一小说| 国产熟女欧美一区二区| 国产精华一区二区三区| 国产免费男女视频| АⅤ资源中文在线天堂| 亚洲av中文字字幕乱码综合| 国产黄a三级三级三级人| 高清在线视频一区二区三区 | 美女脱内裤让男人舔精品视频 | 欧美潮喷喷水| 91久久精品国产一区二区三区| 波多野结衣巨乳人妻| 国产精品精品国产色婷婷| 特级一级黄色大片| 色播亚洲综合网| 国产亚洲精品久久久久久毛片| 精品欧美国产一区二区三| 国内少妇人妻偷人精品xxx网站| 免费在线观看成人毛片| av国产免费在线观看| 亚洲国产精品国产精品| 精品午夜福利在线看| 丝袜喷水一区| 亚洲无线在线观看| 久久久久国产网址| 一本一本综合久久| 男人舔女人下体高潮全视频| 日韩一区二区视频免费看| 亚洲高清免费不卡视频| 国产极品天堂在线| 老师上课跳d突然被开到最大视频| 国产精品女同一区二区软件| 精品一区二区三区人妻视频| 欧美成人免费av一区二区三区| 成年女人永久免费观看视频| 99久久九九国产精品国产免费| 欧美xxxx性猛交bbbb| 久久久久久伊人网av| 熟妇人妻久久中文字幕3abv| 久久久国产成人免费| 亚洲精品日韩av片在线观看| 美女被艹到高潮喷水动态| 一区二区三区免费毛片| 91aial.com中文字幕在线观看| 国产探花在线观看一区二区| 亚洲精品影视一区二区三区av| 神马国产精品三级电影在线观看| 日本一本二区三区精品| 一区二区三区四区激情视频 | 免费黄网站久久成人精品| 91久久精品国产一区二区三区| 欧美日韩一区二区视频在线观看视频在线 | 日韩视频在线欧美| or卡值多少钱| 成年版毛片免费区| 一本一本综合久久| 亚洲精品久久久久久婷婷小说 | 好男人在线观看高清免费视频| 精品人妻偷拍中文字幕| 99热这里只有是精品在线观看| 黄片wwwwww| av黄色大香蕉| 国产精品三级大全| 欧美高清成人免费视频www|